PFIZER
Back to Cashflow Statement
|
PFIZER Last 5 Year Cash Flow from Financing Activities History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Financing Activities | ₹-235 Cr | ₹-346 Cr | ₹-181 Cr | ₹-1,571 Cr | ₹-164 Cr |
What is the latest Cash Flow from Financing Activities ratio of PFIZER ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2024 | ₹-235 Cr |
Mar2023 | ₹-346 Cr |
Mar2022 | ₹-181 Cr |
Mar2021 | ₹-1,571 Cr |
Mar2020 | ₹-164 Cr |
How is Cash Flow from Financing Activities of PFIZER Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2024 | ₹-235 Cr | Negative | |
Mar2023 | ₹-346 Cr | Negative | |
Mar2022 | ₹-181 Cr | Negative | |
Mar2021 | ₹-1,571 Cr | Negative | |
Mar2020 | ₹-164 Cr | - |
Compare Cash Flow from Financing Activities of peers of PFIZER
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
PFIZER | ₹19,398.3 Cr | -1.3% | 4.6% | 1.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹423,771.0 Cr | -3.4% | -0.2% | 18.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹158,175.0 Cr | -2.3% | 3.4% | 55.5% | Stock Analytics | |
CIPLA | ₹120,076.0 Cr | -2.6% | -0.6% | 5.9% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹107,727.0 Cr | -2.3% | -2.1% | 20.4% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹95,853.9 Cr | -2.9% | -0.2% | -8.7% | Stock Analytics |
PFIZER Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
PFIZER | -1.3% |
4.6% |
1.4% |
SENSEX | 0.1% |
4.9% |
7.7% |
You may also like the below Video Courses